Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Neuroscience and Biobehavioral Reviews
|
March 1, 1997
(-)Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells
I A Paterson, A J Barber, D L Gelowitz, et al.
Biochimica Et Biophysica Acta
|
December 29, 1972
Characterization of a chondroitin 4 -sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4 ) released from human blood platelets
A J Barber, R Käser-Glanzmann, M Jakábová, et al.
Diabetes Technology & Therapeutics
|
July 27, 2001
New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets
T W Gardner, D A Antonetti, A J Barber, et al.
Documenta Ophthalmologica. Advances in Ophthalmology
|
July 15, 2000
The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group
T W Gardner, D A Antonetti, A J Barber, et al.
Current Medicinal Chemistry
|
August 21, 2014
Anthocyanins as a potential therapy for diabetic retinopathy
S F Nabavi, S Habtemariam, M Daglia, et al.
The Biochemical Journal
|
December 15, 1996
Histamine reduces ZO-1 tight-junction protein expression in cultured retinal microvascular endothelial cells
T W Gardner, T Lesher, S Khin, et al.
The Journal of Biological Chemistry
|
August 7, 1999
Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors
D A Antonetti, A J Barber, L A Hollinger, et al.
Diabetes
|
December 4, 1998
Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group
D A Antonetti, A J Barber, S Khin, et al.
Journal of Neural Engineering
|
April 16, 2009
Feasibility and safety of longitudinal magnetic resonance imaging in a rodent model with intracortical microwire implants
K J Paralikar, T Neuberger, J T Matsui, et al.
The Journal of Clinical Investigation
|
August 26, 1998
Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin
A J Barber, E Lieth, S A Khin, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Neuroscience and Biobehavioral Reviews
|
March 1, 1997
(-)Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells
I A Paterson, A J Barber, D L Gelowitz, et al.
Biochimica Et Biophysica Acta
|
December 29, 1972
Characterization of a chondroitin 4 -sulfate proteoglycan carrier for heparin neutralizing activity (platelet factor 4 ) released from human blood platelets
A J Barber, R Käser-Glanzmann, M Jakábová, et al.
Diabetes Technology & Therapeutics
|
July 27, 2001
New insights into the pathophysiology of diabetic retinopathy: potential cell-specific therapeutic targets
T W Gardner, D A Antonetti, A J Barber, et al.
Documenta Ophthalmologica. Advances in Ophthalmology
|
July 15, 2000
The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group
T W Gardner, D A Antonetti, A J Barber, et al.
Current Medicinal Chemistry
|
August 21, 2014
Anthocyanins as a potential therapy for diabetic retinopathy
S F Nabavi, S Habtemariam, M Daglia, et al.
The Biochemical Journal
|
December 15, 1996
Histamine reduces ZO-1 tight-junction protein expression in cultured retinal microvascular endothelial cells
T W Gardner, T Lesher, S Khin, et al.
The Journal of Biological Chemistry
|
August 7, 1999
Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors
D A Antonetti, A J Barber, L A Hollinger, et al.
Diabetes
|
December 4, 1998
Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group
D A Antonetti, A J Barber, S Khin, et al.
Journal of Neural Engineering
|
April 16, 2009
Feasibility and safety of longitudinal magnetic resonance imaging in a rodent model with intracortical microwire implants
K J Paralikar, T Neuberger, J T Matsui, et al.
The Journal of Clinical Investigation
|
August 26, 1998
Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin
A J Barber, E Lieth, S A Khin, et al.
Page
of 4